Diego Grauman

Diego Grauman is an accomplished MD, MBA with extensive experience in business and medical fields at global, regional, and country levels.

He has a strong track record of success in strategic marketing, general management, medical strategy, launch excellence, and business development, consistently exceeding targets and implementing innovative business models.

Diego possesses proven managerial skills, international expertise, and the ability to lead multi-functional teams.

His core competencies include strategic planning, cross-functional leadership, clinical development, general management, oncology, radiation oncology, and rare diseases.

Diego's educational background includes finance leadership program at Harvard Business School, MBA from Weatherhead School of Management at Case Western Reserve University, medical fellowships in radiation oncology, and a medical doctorate from University of Buenos Aires.

Diego Grauman has held various prominent positions in organizations such as US Medical Affairs at Oncopeptides AB, General Manager at Roche and Novartis Oncology, Executive Advisor at Lyfegen, and Director roles at Novartis Oncology and Johnson & Johnson.

He has also been involved in business development, marketing consultancy, and medical roles at institutions like MD Anderson Cancer Center, Beaumont Health, and Hospital Italiano de Buenos Aires.

Diego Grauman has a wealth of experience in successfully leading high-performing teams, turning around complex businesses, and implementing effective strategies across different functions within the medical and pharmaceutical sectors.